On October 25, 2023, Lipella Pharmaceuticals Inc. closed the transaction. The company has received $2,000,000 pursuant to Regulation D and included participation from single investor.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.765 USD | +0.34% | +2.68% | -26.31% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.31% | 5.8M | |
+9.04% | 114B | |
+11.36% | 104B | |
-12.43% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.44% | 17.89B | |
+8.11% | 14.28B | |
+34.97% | 12.55B |
- Stock Market
- Equities
- LIPO Stock
- News Lipella Pharmaceuticals Inc.
- Lipella Pharmaceuticals Inc. announced that it has received $1.998685 million in funding